Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Franca M, Placenza"'
Autor:
Jennifer L. Phillips, Natalia Jaworska, Elizabeth Kamler, Venkat Bhat, Jean Blier, Jane A. Foster, Stefanie Hassel, Keith Ho, Lisa McMurray, Roumen Milev, Zahra Moazamigoudarzi, Franca M. Placenza, Stéphane Richard-Devantoy, Susan Rotzinger, Gustavo Turecki, Gustavo H. Vazquez, Sidney H. Kennedy, Pierre Blier, on behalf of the CAN-BIND Investigator Team
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Recent evidence underscores the utility of rapid-acting antidepressant interventions, such as ketamine, in alleviating symptoms of major depressive episodes (MDE). However, to date, there have been limited head-to-head comparisons
Externí odkaz:
https://doaj.org/article/b06f1bf9cf184947884e33f3b741b066
Autor:
Franca M. Placenza, Pierre Blier, Elizabeth Kamler, Jane A. Foster, Jean Blier, Sidney H. Kennedy, Stéphane Richard-Devantoy, Stefanie Hassel, Lisa McMurray, Natalia Jaworska, Zahra Moazamigoudarzi, Roumen Milev, Gustavo H. Vazquez, Susan Rotzinger, Keith Ho, Venkat Bhat, Jennifer L. Phillips, Gustavo Turecki
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Psychiatry
BMC Psychiatry
Background Recent evidence underscores the utility of rapid-acting antidepressant interventions, such as ketamine, in alleviating symptoms of major depressive episodes (MDE). However, to date, there have been limited head-to-head comparisons of intra
Autor:
Stephen Daniels, Daniel J. Mueller, Gustavo Turecki, Benicio N. Frey, Peter Giacobbe, Franca M. Placenza, Stephanie Hassel, Sagar V. Parikh, Claudio N. Soares, Roumen Milev, Rudolf Uher, Thomas Horman, Sidney H. Kennedy, Thomas Lapointe, Faranak Farzan, Pierre Blier, Alexandra Storace, Francesco Leri, Raymond W. Lam, Sakina J. Rizvi, Brett Melanson
Publikováno v:
Journal of affective disorders. 263
Background Reverse translating putative biomarkers of depression from patients to animals is complex because Major Depressive Disorder (MDD) is a highly heterogenous condition. This review proposes an approach to reverse translation based on relating
Autor:
Sidney H, Kennedy, Raymond W, Lam, Susan, Rotzinger, Roumen V, Milev, Pierre, Blier, Jonathan, Downar, Kenneth R, Evans, Faranak, Farzan, Jane A, Foster, Benicio N, Frey, Peter, Giacobbe, Geoffrey B, Hall, Kate L, Harkness, Stefanie, Hassel, Zahinoor, Ismail, Francesco, Leri, Shane, McInerney, Glenda M, MacQueen, Luciano, Minuzzi, Daniel J, Müller, Sagar V, Parikh, Franca M, Placenza, Lena C, Quilty, Arun V, Ravindran, Roberto B, Sassi, Claudio N, Soares, Stephen C, Strother, Gustavo, Turecki, Anthony L, Vaccarino, Fidel, Vila-Rodriguez, Joanna, Yu, Rudolf, Uher
Publikováno v:
The Journal of Clinical Psychiatry. 80
OBJECTIVE To report the symptomatic and functional outcomes in patients with major depressive disorder (MDD) during a 2-phase treatment trial and to estimate the value of early improvement after 2 weeks in predicting clinical response to escitalopram
Autor:
Philip Seeman, Mary V. Seeman, Sidney H. Kennedy, Franca M. Placenza, Peter Giacobbe, Craig J. Hudson
Publikováno v:
Journal of Affective Disorders. 166:139-143
Background and objective Because increased dopamine neurotransmission occurs with most antidepressants, and because antipsychotics cause behavioural supersensitivity to dopamine, short-term low-dose antipsychotic treatment was tested on depressed pat
Autor:
Anthony L, Vaccarino, Kenneth R, Evans, Amir H, Kalali, Sidney H, Kennedy, Nina, Engelhardt, Benicio N, Frey, John H, Greist, Kenneth A, Kobak, Raymond W, Lam, Glenda, MacQueen, Roumen, Milev, Franca M, Placenza, Arun V, Ravindran, David V, Sheehan, Terrence, Sills, Janet B W, Williams
Publikováno v:
Innovations in clinical neuroscience. 13(9-10)
The Depression Inventory Development project is an initiative of the International Society for CNS Drug Development whose goal is to develop a comprehensive and psychometrically sound measurement tool to be utilized as a primary endpoint in clinical
Autor:
Glenda MacQueen, Benicio N. Frey, Susan Rotzinger, Raymond W. Lam, Peter Giacobbe, Zahinoor Ismail, Faranak Farzan, Sagar V. Parikh, Daniel J. Müller, Lena C. Quilty, Mary Pat McAndrews, Francesco Leri, Anthony L. Vaccarino, Harriet Feilotter, Kate L. Harkness, Pierre Blier, Claudio N. Soares, Franca M. Placenza, Roumen Milev, Arun V. Ravindran, Jane A. Foster, Joseph Geraci, Mario Liotti, Stefanie Hassel, Gustavo Turecki, Colleen A. Brenner, Zafiris J. Daskalakis, Jonathan Downar, Tim V. Salomons, Luciano Minuzzi, Geoffrey B. Hall, Fidel Vila-Rodriguez, Moyez Dharsee, Sidney H. Kennedy, Ana Cristina Andreazza, Stephen C. Strother, Kenneth R. Evans
Publikováno v:
BMC Psychiatry
Major Depressive Disorder (MDD) is among the most prevalent and disabling medical conditions worldwide. Identification of clinical and biological markers (“biomarkers”) of treatment response could personalize clinical decisions and lead to better
Publikováno v:
Neuroscience Letters. 390:42-47
A number of neurochemical systems have been implicated in mediating relapse to drug-seeking behavior. Substance P (SP) is a neuropeptide that interacts with some of these systems, suggesting a possible role for SP and its preferred receptor, the neur
Publikováno v:
Psychopharmacology. 177:111-120
The mesocorticolimbic dopamine (DA) system is critically involved in mediating reinstatement of drug-seeking behaviour. Substance P (SP) is a neuropeptide that significantly interacts with the mesocorticolimbic system, therefore suggesting a possible
Autor:
Peter Giacobbe, Susan Rotzinger, Franca M. Placenza, Sakina J. Rizvi, Sidney H. Kennedy, Madelin Donovan
Publikováno v:
International review of psychiatry (Abingdon, England). 23(5)
Antidepressant treatments, including pharmacotherapy and psychotherapy, do not result in remission for the majority of patients with major depressive disorder. The high prevalence of treatment resistant depression (TRD) poses a significant issue for